GlassScriptPhysician profile
Benedict T Chou
NPI 1770759375
$1,904.33
in general payments reported to CMS, 2019-2025
20 companies · $722 in 2025
The $722 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.27 · 2023: $171 · 2024: $994 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.06 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $329.78 | 2024-2025 | Otezla, Enbrel, Evenity |
| Abbvie INC. | $299.43 | 2023-2025 | Rinvoq |
| Ucb, INC. | $205.78 | 2023-2025 | Bimzelx, Briviact, Rystiggo |
| Janssen Biotech, INC. | $194.37 | 2024-2025 | Tremfya |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.99 | 2024-2025 | Ofev |
| Ani Pharmaceuticals, INC. | $140.95 | 2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $116.18 | 2024 | |
| Aurinia Pharma U.S., INC. | $82.06 | 2023-2024 | Lupkynis |
| Mallinckrodt Hospital Products INC. | $80.80 | 2024-2025 | Acthar |
| Argenx US, INC. | $52.78 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Dexcom, INC. | $47.74 | 2023-2024 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $28.90 | 2024 | Austedo Xr |
| Kiniksa Pharmaceuticals International, Plc | $28.90 | 2024 | Arcalyst |
| Lundbeck LLC | $27.04 | 2024 | Vyepti |
| Biogen, INC. | $25.00 | 2023 | Vumerity |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $24.83 | 2024 | Kisunla |
| Acadia Pharmaceuticals INC | $20.80 | 2023 | Nuplazid |
| Genentech, INC. | $17.27 | 2022 | |
| Abbott Laboratories | $14.52 | 2024 | Eterna |
| Livanova USA, INC. | $13.21 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benedict Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.